KALV R&D to Revenue
Kalvista Pharmaceuticals Inc · R&D to Revenue
KALV R&D to Revenue
Latest reported75.58%period ending
KALV FY R&D/Revenue (127.37% → 75.58%)
Latest values, visible window
High-resolution chart · PNG
KALV r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 75.5797% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 316.7376% | |
| 217.1576% | |
| 217.2623% | |
| 842.1543% | |
| 687.3418% | |
| 459.2572% | |
| 1,019.0361% | |
| 127.3732% |